MeSH tree: D27.505.696.663
New Monash University research has found that rapidly reducing or abruptly stopping prescription opioids significantly increases the risk of mental health or substance use-related emergency presentations. For the study, researchers ...
Mar 10, 2026
0
5
A novel team approach founded on a culture change among clinicians and doctor-patient communication successfully reduced post-surgical opioid use, a new study led by University of Rochester Medical Center (URMC) researchers ...
Mar 9, 2026
0
8
More than 70 million baby boomers—those born between 1946 and 1964—are alive today. In 2026, the oldest of them are turning 80. With longer lives often comes more complicated health needs: multiple chronic conditions, long ...
Mar 2, 2026
0
11
For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency department visits and hospitalizations ...
Mar 2, 2026
0
7
Kennon Heard, MD, Ph.D., was skeptical when he first heard about cases in emergency departments of severe, recurring episodes of nausea and vomiting associated with chronic use of marijuana. In 2004, Australian researchers ...
Feb 27, 2026
0
20
Benzodiazepine treatment declined among U.S. adults between 2018 and 2022, with the steepest drop among adults ages 56 and older, according to a new study by researchers at the Columbia University Mailman School of Public ...
Feb 25, 2026
0
6
A large review of opioid pain relievers prescribed for acute pain has found these medicines provide only small, short-term relief for some acute conditions and are ineffective for some others. The study set out to review ...
Feb 25, 2026
0
24
Nearly all the world's 10.6 million children experiencing serious health-related suffering (SHS) live in low- and middle-income countries with little to no access to palliative care or specialized care for their illness, ...
Feb 11, 2026
0
11
A University of Calgary-led international research team has identified a genetic factor that may explain why people respond so differently to opioid pain medications, and why some individuals face greater risk of side effects ...
Feb 3, 2026
0
7
Novel psychoactive substances (NPS) are chemically engineered substances designed to mimic the effects of traditional controlled drugs such as opioids, stimulants, and cannabinoids. These compounds pose significant health ...
Jan 29, 2026
0
8
